Efficacy and Safety of Hospital-Based Group Medical Quarantine for Dialysis Patients Exposed to Coronavirus Disease 2019
Li Zuo,Yu Xu,Xinju Zhao,Wudong Guo,Xiaodan Li,Fuyu Qiao,Liangying Gan,Xiaobo Huang,Jie Gao,Xiaodong Tang,Bo Feng,Jiqiu Kuang,Yizhang Li,Peng Liu,Ying Liu,Lei Wang,Jing Liu,Xiaojun Jia,Luhua Yang,He Zhang,Haibo Wang,Hongsong Chen,Jianliu Wang,Zhancheng Gao,Peifang Wei
DOI: https://doi.org/10.1097/cm9.0000000000001862
2022-01-01
Abstract:To the Editor: The coronavirus disease 2019 (COVID-19) outbreak developed into a pandemic.[1] Patients undergoing hemodialysis (HD) are more susceptible to COVID-19, and isolating patients undergoing HD after exposure are extremely challenging since they frequently travel between their homes and dialysis centers, during which they share a hall for dialysis sessions that may last for hours. We successfully quarantined one infected HD patient and other potentially exposed patients. This experience might serve as an important reference for dialysis centers or for people in similar situations across the country to reduce the spread of COVID-19. This study was approved by the Medicine Ethics Committee of Peking University People's Hospital (No. 2020PHB064-01), and written informed consent was waived by the institutional review board. The present study was triggered by a 78-year-old female inpatient with uremia who had been undergoing HD regularly for over 6 months. The patient developed a fever on January 30, 2020, but was not diagnosed with COVID-19 until her daughter and son-in-law were diagnosed on February 17, 2020, after having visited her in the hospital without facemasks. We realized that 143 patients in our dialysis center might have had direct or indirect contact and required medical quarantine. Exposed patients were graded based on whether they were adjacent to the infected individual during a dialysis session. It was recommended that the exposed patients be isolated for at least 14 days based on the virus incubation period as per local regulations.[2,3] Although patients and medical staff had worn masks before the patients’ symptoms appeared, whether anyone was still in the incubation period was uncertain. HD patients are not suitable candidates for self-quarantine at home, as they must frequently commute to dialysis centers for treatment. Hotel-based group quarantine is also not recommended because these patients usually have severe comorbidities, and their health and safety may not be guaranteed in these locations. A hospital-based group medical quarantine (H-GMQ) was implemented for this exposed patient cohort. H-GMQ enables early detection and intervention to avoid further spread of COVID-19, similar to Fangcang shelter hospitals.[4] An H-GMQ taskforce (TF) was established to quarantine the dialysis population immediately. Several workgroups (WGs) were organized under the leadership of these TFs. WGs created a series of emergency response plans and flow charts to guide the following procedures: prevention of COVID-19 cross-infection in quarantine areas during transportation and in dialysis halls, screening of new COVID-19 cases, responding to medical emergencies, handling of psychological problems, provision of nutritional diets for patients undergoing maintenance hemodi-alysis (MHD), etc. The working missions, plans, and flow charts were updated to fulfill unmet needs over the quarantine period, and challenges that arose during this time were managed accordingly. Each of the 143 dialysis patients was isolated in separate rooms in a branched area of the hospital. Patients were required to wear masks during transportation and dialysis sessions. Medical staff were required to use appropriate personal protective equipment in accordance with local requirements.[5] Nasopharyngeal swab specimens were collected from all individuals who possibly had contact with the infected patient. Coronavirus nucleic acid assays were used to test the samples in the referral laboratory. The patients’ body temperatures and respiratory symptoms were monitored twice and once daily, respectively, during the quarantine period. If a patient had any suspected symptoms, they were retested, and chest computed tomography (CT) was performed according to the recommendations of the expert team. Ward rounds were performed daily. The medical team members would offer assistance if patients had concerns or felt unwell. All patients underwent psychological evaluations on the 12th day of medical quarantine. The self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were used to evaluate mental health, and we compared these scores with the results from December, 2019. Continuous variables were expressed as mean ± standard deviation or median (interquartile range), and categorical variables were expressed as numbers and percentages. Differences in continuous variables with normal distribution were analyzed by t test. P value of < 0.05 was considered to be statistically significant. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). The median age of HD patients was 61 years, and 65.7% (94/143) were men [Table 1]. The median dialysis vintage was 6.5 years, and 62.9% (90/143) had been undergoing MHD for 5 years or longer. Twelve dialysis patients were considered heavily exposed as they were adjacent to the original patient dialysis station; all other patients in the dialysis center were indirectly exposed. Coronavirus nucleic acid assays were conducted by reverse-transcription polymerase chain reaction (RT-PCR) with nasopha-ryngeal swabs from quarantined patients; all results were negative. Three dialysis patients presenting with fever were retested for COVID-19 during the 14-day quarantine using RT-PCR and chest CT. Each of these patients tested negative. One patient developed acute congestive heart failure and one myocardial infarction, but both improved quickly after receiving appropriate treatment. Table 1 - Baseline demographics and comorbid conditions of the dialysis patients exposed to a COVID-19 patient (n= 143). Items Values Age (years), median (Q1, Q3) 61 (48, 71) Male, n (%) 94 (65.7) Dialysis vintage (years), median (Q1, Q3) 6.5 (2.5, 11.3) Assigned primary causes of ESKD, n (%) Chronic glomerulonephritis 65 (45.5) Diabetic nephropathy 27 (18.9) Hypertension 16 (11.2) Others 35 (24.5) Patients with at least one comorbidity, n (%) Coronary artery disease 25 (17.5) History of angina 11 (7.7) Chronic heart failure 13 (9.1) Neoplasm 12 (8.4) Arrhythmia 6 (4.2) Stroke 6 (4.2) Cirrhosis 2 (1.4) Peptic ulcer 1 (0.7) Patients with comorbidities, n (%) No comorbidity 96 (67.1) One comorbid disease 32 (22.4) Two comorbid diseases 12 (8.4) Three or more comorbid diseases 3 (2.1) COVID-19: Coronavirus disease 2019; ESKD: End-stage kidney disease. The clinical status and laboratory values of the chronic HD patients were relatively stable. Their dry weights were slightly below baseline (65.5 ± 12.1 kg vs. 65.7 ± 12.2 kg, P < 0.01), while their heart rates (78.7 ± 10.7 beats per minute [bpm] vs. 74.4 ± 10.1 bpm, P < 0.001) and systolic (155.8 ± 18.4 mmHg vs. 153.7 ± 17.8 mmHg, P = 0.03) and diastolic (77.3 ± 13.6 mmHg vs. 76.0 ± 12.6 mmHg, P = 0.03) blood pressures were slightly elevated above baseline, which may have been due to their fear of being infected. Our data suggest that patients’ anxiety and depression were not exacerbated during the quarantine period (SAS score: 41.0 ± 9.0 vs. 41.0 ± 9.0, P = 0.95; SDS score: 47.1 ± 11.3 vs. 46.7 ± 11.9, P = 0.71). Timely and effective psychological counseling may ameliorate possible anxiety and depression. During the 14-day period, all patients remained on their regular dialysis regimens, and no new COVID-19 cases emerged. Although the patient first infected with COVID-19 remained in our dialysis center for 14 days after initial symptom presentation, no new cases emerged. We attributed this result to two possible causes: (1) a relatively comprehensive system for surveillance, prevention, and control of nosocomial infections. We employ full-time infection control practitioners at our hospital; measures and procedures to prevent nosocomial infections have always been strictly followed. All patients undergoing HD and medical staff were asked to wear facemasks before they entered the dialysis center immediately after the first case of COVID-19 was reported. Everyone complied with this requirement. (2) The patient with COVID-19 was bedridden, and her activity was restricted; therefore, the chance of viral spread was limited. Two major medical events, outlined above, occurred during quarantine. The preplanned procedures for responding to medical emergencies were followed, and the diagnoses and treatment processes ran smoothly. Being in a hospital with emergency plans in place allowed them to receive optimal treatment. Using a similar H-GMQ model may maximize clinicians’ ability to integrate resources and protect vulnerable patients. In summary, the H-GMQ program was conducted successfully using preplanned flow charts. No new cases of COVID-19 were diagnosed, and all emergent medical events were managed successfully. H-GMQ was demon-strably feasible in practice, effective for containing COVID-19, and safe for the prevention of and response to medical emergency events when dealing with patients undergoing dialysis who were exposed to COVID-19. Acknowledgements The author thank colleagues and coordinators from Peking University Health Science Center and Beijing Center for Disease Prevention and Control for their guidance and facilitation in organizing and implementing of H-GMQ program. We greatly appreciate the excellent work of all our staff involved in this program, especially those in the dialysis center. We also want to thank our patients and their family for their understanding and cooperation. Funding This work was supported by Peking University Special Fund for COVID-19 Prevention and Control (No. PKU2020PKYZX001). Conflicts of interest None.